05:18 PM EDT, 10/03/2025 (MT Newswires) -- Yvonne Greenstreet, Director, Chief Executive Officer, on October 01, 2025, sold 8,924 shares in Alnylam Pharmaceuticals ( ALNY ) for $4,034,085. Following the Form 4 filing with the SEC, Greenstreet has control over a total of 65,816 common shares of the company, with 65,409 shares held directly and 407 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1178670/000173527625000116/xslF345X05/edgardoc.xml